Medilink Therapeutics Investors

16 investors on Angel Roster list Medilink Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in China, the United States and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name Medilink Therapeutics can appear together.

Investors listed
16
With verified email
56%
Most common stage
Seed
Top location
China

Updated October 13, 2026 · How we compile this data

Top 16 Medilink Therapeutics investors

The most complete profiles first. Showing 16 of 16.

  • Jing WuVerified

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsAutonomous VehiclesSports

    Portfolio: Saints Sages Medical, Berry Genomics, Broncus Technologies, Yunji Technology and 78 more

    Verified email available

  • Nisa LeungVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Series BSeries AHealth CareHospitalsAutonomous VehiclesComputer Vision

    Portfolio: Saints Sages Medical, Berry Genomics, DiNovA Medtech, Broncus Technologies and 119 more

    Verified email available

  • Alex ZhouVerified

    Venture Capital · China

    Health CareHospitalsAutonomous VehiclesComputer Vision

    Portfolio: Saints Sages Medical, Berry Genomics, Broncus Technologies, Yunji Technology and 78 more

    Verified email available

  • Andy LinVerified

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceEmerging Markets

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Verified email available

  • Grace LeeVerified

    Venture Capital, Private Equity Firm, Investment Partner

    Health CareHospitalsAutonomous VehiclesComputer Vision

    Portfolio: Saints Sages Medical, Berry Genomics, Broncus Technologies, Yunji Technology and 78 more

    Verified email available

  • Jason ZhaoVerified

    Private Equity Firm · China

    Health CareGeneticsLife ScienceBiotechnology

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Verified email available

  • Jay GuVerified

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceEmerging Markets

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Verified email available

  • Kuantai YehVerified

    Venture Capital · China

    Health CareHospitalsAutonomous VehiclesComputer Vision

    Portfolio: Saints Sages Medical, Berry Genomics, Broncus Technologies, Yunji Technology and 78 more

    Verified email available

  • Linda CaiVerified

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceEmerging Markets

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Verified email available

  • Duane Kuang

    Venture Capital, Investor · Hong Kong

    SeedHealth CareHospitalsAutonomous VehiclesSports

    Portfolio: Saints Sages Medical, Berry Genomics, Intelligent Automation, Broncus Technologies and 109 more

    Contact details available

  • William Hu

    Venture Capital, Private Equity Firm, Investment Partner · China

    SeedHealth CareHospitalsAutonomous VehiclesSports

    Portfolio: Saints Sages Medical, Berry Genomics, Broncus Technologies, Yunji Technology and 78 more

    Contact details available

  • Brian Chi

    Private Equity Firm · China

    Health CareGeneticsLife ScienceBiotechnology

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Contact details available

  • Chengbin Li

    Private Equity Firm · China

    Health CareGeneticsLife ScienceBiotechnology

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Contact details available

  • Janet Yu

    Venture Capital · China

    Health CareHospitalsAutonomous VehiclesComputer Vision

    Portfolio: Saints Sages Medical, Berry Genomics, Broncus Technologies, Yunji Technology and 78 more

    Contact details available

  • Lisa Ye

    Private Equity Firm · China

    Health CareGeneticsLife ScienceBiotechnology

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Contact details available

  • Roy Xie

    Venture Capital, Private Equity Firm · China

    Health CareGeneticsLife ScienceEmerging Markets

    Portfolio: InfiNovo, HYGEIA Healthcare Group, Phyplus, Immupeutics Medicine and 53 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Medilink Therapeutics investors are on Angel Roster?

Angel Roster lists 16 Medilink Therapeutics investors. 9 of them (56%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (12), Private Equity Firms (11) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Medilink Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (3), Series B (1) and Series A (1).

Where are Medilink Therapeutics investors based?

Most are based in China (12), the United States (2) and Hong Kong (1).

Which companies have Medilink Therapeutics investors backed?

The most-backed portfolio companies among them are Abbisko Therapeutics (16), Chaodian Culture (16), Kangning Hospital (8), ByteDance (8) and Sinovent (8).

How do I contact Medilink Therapeutics investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.